Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Smith

Showing results (71-80 of 591) with videos related to

Pageof 60
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?Bruce E Hillner, Thomas J Smith
Cancer Journal (Sudbury, Mass.)|October 5, 2010
Palliative chemotherapy: when is it worth it and when is it not?Keith M Swetz, Thomas J Smith
Structure (London, England : 1993)|February 18, 2010
SusG: a unique cell-membrane-associated alpha-amylase from a prominent human gut symbiont targets complex starch moleculesNicole M Koropatkin, Thomas J Smith
Annual Review of Public Health|March 20, 2014
The growth of palliative care in the United StatesMark T Hughes, Thomas J Smith
JAMA Network Open|April 6, 2019
The Cost of PainThomas J Smith, Bruce E Hillner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Comment on pegylated liposomal Doxorubicin plus docetaxel in metastatic breast cancerThomas J Smith, Bruce E Hillner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 22, 2011
Allocating cancer-directed expenditures: tensions between prevention, early detection and treatment is unnecessaryBruce E Hillner, Thomas J Smith
Methods in Enzymology|March 23, 2011
Mutagenesis of soluble methane monooxygenaseThomas J Smith, J Colin Murrell
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Real-World Conundrums and Biases in the Use of White Cell Growth FactorsThomas J Smith, Bruce E Hillner
The Lancet. Oncology|February 19, 2014
Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer careRonan J Kelly, Thomas J Smith
Pageof 60

Showing results (71-80 of 591) with videos related to

Sort By:
Pageof 60
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?Bruce E Hillner, Thomas J Smith
Cancer Journal (Sudbury, Mass.)|October 5, 2010
Palliative chemotherapy: when is it worth it and when is it not?Keith M Swetz, Thomas J Smith
Structure (London, England : 1993)|February 18, 2010
SusG: a unique cell-membrane-associated alpha-amylase from a prominent human gut symbiont targets complex starch moleculesNicole M Koropatkin, Thomas J Smith
Annual Review of Public Health|March 20, 2014
The growth of palliative care in the United StatesMark T Hughes, Thomas J Smith
JAMA Network Open|April 6, 2019
The Cost of PainThomas J Smith, Bruce E Hillner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Comment on pegylated liposomal Doxorubicin plus docetaxel in metastatic breast cancerThomas J Smith, Bruce E Hillner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 22, 2011
Allocating cancer-directed expenditures: tensions between prevention, early detection and treatment is unnecessaryBruce E Hillner, Thomas J Smith
Methods in Enzymology|March 23, 2011
Mutagenesis of soluble methane monooxygenaseThomas J Smith, J Colin Murrell
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Real-World Conundrums and Biases in the Use of White Cell Growth FactorsThomas J Smith, Bruce E Hillner
The Lancet. Oncology|February 19, 2014
Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer careRonan J Kelly, Thomas J Smith
Pageof 60